InfusionCapital announces agreement with XELR8, Inc. AMEX:PRH

Orlando, Florida, October 3, 2005 – InfusionCapital today announced that it will provide investment banking and investor relation services for XELR8, Inc.  Headquartered in Denver, Colorado, XELR8 is a publicly owned company that provides high-quality meals, drinks, snacks, and nutritional supplements. 

“We are very excited to be working with XELR8 and I know that our two companies will enhance share holder value.  I have worked with Sandy Greenburg, CEO of XELR8, for over ten years and feel honored to be working with him on his latest venture,” said Kelly McCarthy, President of InfusionCapital.

About XELR8, Inc.

XELR8 is a provider of nutritional supplements and health foods to conscious consumers through direct, person-to-person selling by independent distributors.  The company has leveraged intellectual capital from around the world to ensure the quality of its eat-drink-snack products and has contracted to receive 2 to 3 patents every single month.  The products offer high-quality ingredients in optimal dosages, meet pharmaceutical production standards and are based on hundreds of clinical research studies.  For further information on XELR8, visit www.XELR8.com.     

About InfusionCapital

InfusionCapital provides a uniquely integrated approach to capital formation. They have the experience and expertise to guide clients through complex capital formation processes. They leverage their years of investment banking experience on Wall Street, and their long term relationships with leading portfolio management firms, key investment managers, and national brokerages to help clients make the right connections and deliver a consistently powerful message that gets results. For further information about InfusionCapital, visit www.infusioncapital.com.

                                                              ###

For more information, contact Gina Andrews, Communications

407-566-1010 or by email at gina@InfusionCapital.com.